HSKA
$207.30
Heska
$10.77
5.48%
HSKA
Earnings Whisper ®
N/A
1st Quarter March 2021
Consensus:  ($0.14)
Revenue:  N/A
Tuesday
Feb 23
8:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when HSKA reports earnings?
Beat
Meet
Miss

Where is HSKA's stock price going from here?
Up
Flat
Down
Stock chart of HSKA
Analysts
Summary of analysts' recommendations for HSKA
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Heska Corporation sells advanced veterinary diagnostic and specialty products. Heska's state-of-the-art offerings include blood testing instruments and supplies, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The Company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled support to veterinarians.
Peers
Petco Health and Wellness CompanyKindred Biosciences